List of Tables
Table 1. Gestational Trophoblastic Disease Market Trends
Table 2. Gestational Trophoblastic Disease Market Drivers & Opportunity
Table 3. Gestational Trophoblastic Disease Market Challenges
Table 4. Gestational Trophoblastic Disease Market Restraints
Table 5. Global Gestational Trophoblastic Disease Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Gestational Trophoblastic Disease Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Gestational Trophoblastic Disease Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Gestational Trophoblastic Disease Product Type
Table 9. Key Companies Time to Begin Mass Production of Gestational Trophoblastic Disease
Table 10. Global Gestational Trophoblastic Disease Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gestational Trophoblastic Disease as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Gestational Trophoblastic Disease Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Gestational Trophoblastic Disease Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Gestational Trophoblastic Disease Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Gestational Trophoblastic Disease Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Gestational Trophoblastic Disease Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Gestational Trophoblastic Disease Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Gestational Trophoblastic Disease Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Gestational Trophoblastic Disease Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Gestational Trophoblastic Disease Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Gestational Trophoblastic Disease Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Gestational Trophoblastic Disease Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Gestational Trophoblastic Disease Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Gestational Trophoblastic Disease Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Gestational Trophoblastic Disease Sales Value by Region (2019-2024) & (%)
Table 27. Global Gestational Trophoblastic Disease Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Gestational Trophoblastic Disease Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Gestational Trophoblastic Disease Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Gestational Trophoblastic Disease Sales Value, (2025-2030) & (US$ Million)
Table 31. Bristol Myers Squibb Basic Information List
Table 32. Bristol Myers Squibb Description and Business Overview
Table 33. Bristol Myers Squibb Gestational Trophoblastic Disease Products, Services and Solutions
Table 34. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of Bristol Myers Squibb (2019-2024)
Table 35. Bristol Myers Squibb Recent Developments
Table 36. Antares Pharma Basic Information List
Table 37. Antares Pharma Description and Business Overview
Table 38. Antares Pharma Gestational Trophoblastic Disease Products, Services and Solutions
Table 39. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of Antares Pharma (2019-2024)
Table 40. Antares Pharma Recent Developments
Table 41. Novartis AG Basic Information List
Table 42. Novartis AG Description and Business Overview
Table 43. Novartis AG Gestational Trophoblastic Disease Products, Services and Solutions
Table 44. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of Novartis AG (2019-2024)
Table 45. Novartis AG Recent Developments
Table 46. Accord Healthcare Limited Basic Information List
Table 47. Accord Healthcare Limited Description and Business Overview
Table 48. Accord Healthcare Limited Gestational Trophoblastic Disease Products, Services and Solutions
Table 49. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of Accord Healthcare Limited (2019-2024)
Table 50. Accord Healthcare Limited Recent Developments
Table 51. Eli Lilly and Company Basic Information List
Table 52. Eli Lilly and Company Description and Business Overview
Table 53. Eli Lilly and Company Gestational Trophoblastic Disease Products, Services and Solutions
Table 54. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of Eli Lilly and Company (2019-2024)
Table 55. Eli Lilly and Company Recent Developments
Table 56. Sanofi Basic Information List
Table 57. Sanofi Description and Business Overview
Table 58. Sanofi Gestational Trophoblastic Disease Products, Services and Solutions
Table 59. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of Sanofi (2019-2024)
Table 60. Sanofi Recent Developments
Table 61. Bayer AG Basic Information List
Table 62. Bayer AG Description and Business Overview
Table 63. Bayer AG Gestational Trophoblastic Disease Products, Services and Solutions
Table 64. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of Bayer AG (2019-2024)
Table 65. Bayer AG Recent Developments
Table 66. Amgen Basic Information List
Table 67. Amgen Description and Business Overview
Table 68. Amgen Gestational Trophoblastic Disease Products, Services and Solutions
Table 69. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of Amgen (2019-2024)
Table 70. Amgen Recent Developments
Table 71. Merck KGaA Basic Information List
Table 72. Merck KGaA Description and Business Overview
Table 73. Merck KGaA Gestational Trophoblastic Disease Products, Services and Solutions
Table 74. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of Merck KGaA (2019-2024)
Table 75. Merck KGaA Recent Developments
Table 76. Teva Pharmaceuticals Basic Information List
Table 77. Teva Pharmaceuticals Description and Business Overview
Table 78. Teva Pharmaceuticals Gestational Trophoblastic Disease Products, Services and Solutions
Table 79. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of Teva Pharmaceuticals (2019-2024)
Table 80. Teva Pharmaceuticals Recent Developments
Table 81. B.P Pharma Basic Information List
Table 82. B.P Pharma Description and Business Overview
Table 83. B.P Pharma Gestational Trophoblastic Disease Products, Services and Solutions
Table 84. Revenue (US$ Million) in Gestational Trophoblastic Disease Business of B.P Pharma (2019-2024)
Table 85. B.P Pharma Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Gestational Trophoblastic Disease Downstream Customers
Table 89. Gestational Trophoblastic Disease Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Gestational Trophoblastic Disease Product Picture
Figure 2. Global Gestational Trophoblastic Disease Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Gestational Trophoblastic Disease Sales Value (2019-2030) & (US$ Million)
Figure 4. Gestational Trophoblastic Disease Report Years Considered
Figure 5. Global Gestational Trophoblastic Disease Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gestational Trophoblastic Disease Revenue in 2023
Figure 7. Gestational Trophoblastic Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Chemotherapy Picture
Figure 9. Surgery Picture
Figure 10. Radiation Therapy Picture
Figure 11. Others Picture
Figure 12. Global Gestational Trophoblastic Disease Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Gestational Trophoblastic Disease Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospitals
Figure 15. Product Picture of Clinics
Figure 16. Product Picture of Cancer Research Institutes
Figure 17. Product Picture of Others
Figure 18. Global Gestational Trophoblastic Disease Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Gestational Trophoblastic Disease Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Gestational Trophoblastic Disease Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Gestational Trophoblastic Disease Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Gestational Trophoblastic Disease Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Gestational Trophoblastic Disease Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Gestational Trophoblastic Disease Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Gestational Trophoblastic Disease Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Gestational Trophoblastic Disease Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Gestational Trophoblastic Disease Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Gestational Trophoblastic Disease Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Gestational Trophoblastic Disease Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Gestational Trophoblastic Disease Sales Value (%), (2019-2030)
Figure 31. United States Gestational Trophoblastic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Gestational Trophoblastic Disease Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Gestational Trophoblastic Disease Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Gestational Trophoblastic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Gestational Trophoblastic Disease Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Gestational Trophoblastic Disease Sales Value by Application (%), 2023 VS 2030
Figure 37. China Gestational Trophoblastic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Gestational Trophoblastic Disease Sales Value by Type (%), 2023 VS 2030
Figure 39. China Gestational Trophoblastic Disease Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Gestational Trophoblastic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Gestational Trophoblastic Disease Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Gestational Trophoblastic Disease Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Gestational Trophoblastic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Gestational Trophoblastic Disease Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Gestational Trophoblastic Disease Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Gestational Trophoblastic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Gestational Trophoblastic Disease Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Gestational Trophoblastic Disease Sales Value by Application (%), 2023 VS 2030
Figure 49. India Gestational Trophoblastic Disease Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Gestational Trophoblastic Disease Sales Value by Type (%), 2023 VS 2030
Figure 51. India Gestational Trophoblastic Disease Sales Value by Application (%), 2023 VS 2030
Figure 52. Gestational Trophoblastic Disease Industrial Chain
Figure 53. Gestational Trophoblastic Disease Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
